Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

PURPOSE: Non-small-cell lung cancer (NSCLC) has a large worldwide prevalence with a high mortality rate. Chemotherapy has offered modest improvements in survival over the past two decades. Immune checkpoint modulation with programmed death-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibition has...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Oncol
Main Authors: Iafolla, Marco A. J., Juergens, Rosalyn A.
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2017
主題:
Oncology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382272/
https://ncbi.nlm.nih.gov/pubmed/28428947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00067
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍